Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
NACompletedINTERVENTIONAL
Enrollment
39
Participants
Timeline
Start Date
October 1, 2003
Primary Completion Date
July 26, 2018
Study Completion Date
July 26, 2018
Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL
donor lymphocytes
Given IV
Trial Locations (1)
14263-0001
Roswell Park Cancer Institute, Buffalo
All Listed Sponsors
lead
Roswell Park Cancer Institute
OTHER
NCT00534118 - Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter